BREO Ellipta Drugs Market Overview
The BREO Ellipta Drugs Market represents the global commercial landscape for Breo Ellipta, a once-daily inhaled combination therapy used for the long-term management of chronic respiratory diseases, primarily Chronic Obstructive Pulmonary Disease (COPD) and asthma. Developed and marketed by GSK plc, BREO Ellipta combines fluticasone furoate (an inhaled...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
